Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current Assets:
Cash and cash equivalents	$ 17,371,217	$ 12,241,261
Accounts receivable, net	765,226	924,916
Inventories, net	793,791	707,114
Prepaid expenses and other	998,763	572,684
Total Current Assets	19,928,997	14,445,975
Equipment, net	210,296	95,023
Operating lease assets with right-of-use	783,816	168,784
Total Assets	20,923,109	14,709,782
Current Liabilities:
Accounts payable and accrued expenses	3,892,475	2,848,904
Current operating lease liability	204,460	18,289
Deferred revenue		2,512
Total Current Liabilities	4,096,935	2,869,705
Non-current operating lease liability	644,107	155,148
Deferred revenue	1,495	1,495
Other long-term liabilities	113,423	118,060
Total Liabilities	4,855,960	3,144,408
Commitments and Contingencies
Stockholders’ Equity:
Preferred stock, $0.0001 par value; 25,000,000 shares authorized; no shares issued or outstanding
Common stock par value $0.0001 per share 100,000,000 shares authorized; 5,604,036 and 4,593,184 shares issued as of March 31, 2021 and December 31, 2020, respectively, and 5,604,009 and 4,593,157 shares outstanding as of March 31, 2021 and December 31, 2020, respectively.	560	457
Additional paid-in capital	86,728,107	79,273,964
Accumulated other comprehensive loss	(4,367)	(12,690)
Accumulated deficit	(70,650,687)	(67,689,893)
Treasury stock, 27 shares at cost	(6,464)	(6,464)
Total Stockholders’ Equity	16,067,149	11,565,374
Total Liabilities and Stockholders’ Equity	$ 20,923,109	$ 14,709,782